ライフサイエンスコーパス: sinusitis

1 oal calories received, nasal ulceration, and sinusitis.

2 All Cby(-/-) mice develop rhinitis and sinusitis.

3 in and topical budesonide in acute maxillary sinusitis.

4 is increasingly linked to severe asthma and sinusitis.

5 found in isolates from patients with chronic sinusitis.

6 vered from isolates from patients with acute sinusitis.

7 ary sinus collapse in the setting of chronic sinusitis.

8 specific URTIs to 69% of patients with acute sinusitis.

9 licated and those that precede an episode of sinusitis.

10 olds and >3,000 ng/ml in 62% of persons with sinusitis.

11 n subnucleus caudalis following induction of sinusitis.

12 second was a 79-year-old female with chronic sinusitis.

13 lar secretions in the maxillary sinus during sinusitis.

14 llnesses in 31 patients met the criteria for sinusitis.

15 ry process and painful symptoms accompanying sinusitis.

16 h Th2-type allergic and Th1-type nonallergic sinusitis.

17 ent with asthma that developed at age 37 and sinusitis.

18 incidental findings in patient with chronic sinusitis.

19 for empirical antibiotic selection in acute sinusitis.

20 influence or exacerbate the pathogenesis of sinusitis.

21 l fibroblasts from controls without polypoid sinusitis.

22 as influence on the development of maxillary sinusitis.

23 f paranasal sinuses and chronic or recurrent sinusitis.

24 es in adults with clinically diagnosed acute sinusitis.

25 therapy as a first-line therapy for chronic sinusitis.

26 old (53.4%), acute bronchitis (31.3%), acute sinusitis (13.6%), or acute laryngitis (1.6%).

27 ratory tract infections (URTIs) (24%), acute sinusitis (24%), acute bronchitis (23%), otitis media (5

28 is (62.4%), gastroesophageal reflux (42.1%), sinusitis (37.9%), nasal polyposis (30.2%), and allergic

29 and 7.7%), nasopharyngitis (6.9% and 8.0%), sinusitis (4.0% and 6.3%), and viral upper respiratory t

30 nivariate analyses, cases with GERD had more sinusitis (4.2% vs. 1.4%, P < 0.0001), laryngitis (0.7%

31 of asthma was 27.6% (number at risk: 7027), sinusitis 42.3% (5870), and gastro-oesophageal reflux di

32 A streptococcal pharyngitis; and 4234, acute sinusitis), 4307 (14%) were prescribed broad-spectrum an

33 requent comorbidities were rhinitis (84.0%), sinusitis (47.8%), and gastroesophageal reflux disease (

34 n cold and nonspecific URTIs, 53% with acute sinusitis, 62% with acute bronchitis, and 65% with otiti

35 ore ARI: pneumonia (537), bronchitis (2931), sinusitis (717) and non-specific ARI (145).

36 PCR results occurred in patients with fungal sinusitis (8) and limb infection (3).

37 ars of follow-up) in the presence of chronic sinusitis (84%).

38 history of a sinus surgery (87.3%), chronic sinusitis (85.7%), presence of ostium stenosis (68.3%),

39 A streptococcal pharyngitis; and 667, acute sinusitis), 868 (35%) were prescribed broad-spectrum ant

40 ompromised or diabetic) with invasive fungal sinusitis (88% mucormycetes, Aspergillus) who received i

41 ented here with 14 years of chronic purulent sinusitis, a chronic fungal rash of the scrotum, and chr

42 are the etiologic agents of acute bacterial sinusitis (ABS).

43 Of 20 adults with acute community-acquired sinusitis (ACAS), rhinovirus was detected in specimens f

44 practice in the United States are for acute sinusitis, acute pharyngitis, acute bronchitis, and nons

45 GERD remained a significant risk factor for sinusitis (adjusted odds ratio [OR], 2.3; 95% confidence

46 Antibiotic prescribing was highest for sinusitis (adjusted proportion, 86%) and bronchitis (85%

47 Acute fungal sinusitis (AFS) is a devastating disease of the paranasa

48 ogression of fulminant acute invasive fungal sinusitis (AIFS), data on prognostic factors have been d

49 1) percent predicted values, whereas chronic sinusitis, allergic rhinitis, and gastroesophageal reflu

50 exacerbations (n = 3830) had higher rates of sinusitis, allergy-related diagnoses or medications, pne

51 aled a prevalent history of otitis media and sinusitis among most individuals with Myhre syndrome.

52 ger with a new outpatient diagnosis of acute sinusitis and a same-day new prescription dispensation o

53 ronic postnasal drainage without evidence of sinusitis and allergies, twice-daily therapy with proton

54 ry tract infections, including otitis media, sinusitis and chronic obstructive pulmonary disease.

55 Imaging showed acute sinusitis and extensive orbital cellulitis.

56 Chronic sinusitis and gastroesophageal reflux were also associat

57 13 and August 2014 in 60 adults with chronic sinusitis and nasal polyposis refractory to intranasal c

58 Among adults with symptomatic chronic sinusitis and nasal polyposis refractory to intranasal c

59 us clinical samples in patients with chronic sinusitis and orbital cellulitis.

60 mined; patients with first-onset or allergic sinusitis and pregnant females were excluded.

61 All had a prior history of chronic sinusitis and presented with cough, dyspnea, and sputum

62 nician to the possibility of allergic fungal sinusitis and prompt other diagnostic studies to establi

63 patients with biopsy-proven invasive fungal sinusitis and radiographic evidence of orbital involveme

64 advertently isolated from a cat with chronic sinusitis and rhinitis when cytopathic effects were obse

65 Recent publications in the areas of sinusitis and upper respiratory infections are also revi

66 The large overlap between symptoms of acute sinusitis and viral upper respiratory tract infection su

67 ng the following key terms: ["chronic" AND "*sinusitis"] AND [PROM OR patient reported outcome measur

68 e >38.5 degrees C), 7 had muscle pain, 6 had sinusitis, and 6 had biopsy evidence of eosinophilic tis

69 rrence of wheezing, cough, mucus production, sinusitis, and acute bronchitis.

70 chronic rhinosinusitis, granulomatous fungal sinusitis, and acute fulminant fungal rhinosinusitis.

71 and antibiotic prescribing for pharyngitis, sinusitis, and acute otitis media (AOM) in the United St

72 cause of bacteremia, meningitis, pneumonia, sinusitis, and acute otitis media in children.

73 ivity costs associated with GAS pharyngitis, sinusitis, and acute otitis media.

74 Collectively, GAS-attributable pharyngitis, sinusitis, and AOM cause 26.9 (95% CI, 23.9-30.8) outpat

75 mucosal infections, including otitis media, sinusitis, and bronchitis.

76 ry infections, including acute otitis media, sinusitis, and chronic bronchitis, which are preceded by

77 arrhalis, a causative agent of otitis media, sinusitis, and exacerbation of bronchitis, has acquired

78 ual incidence of physical disorders (asthma, sinusitis, and gastro-oesophageal reflux disease), menta

79 ologic complications (membrane perforations, sinusitis, and intraoperative and/or postoperative hemor

80 iation in patients with chronic or recurrent sinusitis, and it was detected in 48.8% of cases.

81 m infection, recurrent Staphylococcus aureus sinusitis, and multiple adverse drug reactions whose T c

82 an important cause of pneumonia, meningitis, sinusitis, and otitis media.

83 outbreaks, including pneumonia, bronchitis, sinusitis, and otitis media.

84 ients with chronic hyperplastic eosinophilic sinusitis, and patients with AERD, and their cellular so

85 rst-line antibiotics for acute otitis media, sinusitis, and pharyngitis.

86 moniae is the leading cause of otitis media, sinusitis, and pneumonia.

87 Patients had recurrent otitis media, sinusitis, and pneumonias; recurrent Staphylococcus aure

88 ed by notable peripheral blood eosinophilia, sinusitis, and pulmonary nodules on radiographic evaluat

89 rty, obesity, early onset of puberty, active sinusitis, and skin test sensitization were significant

90 roups of children being diagnosed with acute sinusitis, and subsequently treated with antibiotics, de

91 ystemic corticosteroid regimens, episodes of sinusitis, and surgery was significantly lower both at 1

92 a 36-year-old male with frontal and ethmoid sinusitis, and the second was a 79-year-old female with

93 ain viruses are more likely to lead to acute sinusitis, and we compare viruses identified at the time

94 In children with acute sinusitis, antibiotic treatment had minimal benefit for

95 sia (aOR 2.20, 95% CI 2.15-2.25) and chronic sinusitis (aOR 2.12, 95% CI 1.99-2.26).

96 partners compared to 0-1 partners), chronic sinusitis (AOR, 3.1; 95% CI, 1.5-6.7), and cervical HPV

97 Asthma and chronic sinusitis are inexplicably common airway diseases that a

98 efficacy of antibiotic treatment of chronic sinusitis are surprisingly few in number and the results

99 icated urinary tract infection (uUTI), acute sinusitis (AS), and acute exacerbation of chronic obstru

100 izumab may be effective for otitis media and sinusitis associated with EGPA.

101 zumab was used for treating otitis media and sinusitis associated with EGPA.

102 -2019 for acute otitis media, pneumonia, and sinusitis associated with PCV15- and PCV20-additional (n

103 dren aged 2 to 11 years diagnosed with acute sinusitis based on clinical criteria.

104 tile cilia, causing symptoms such as chronic sinusitis, bronchiectasis and frequently SIT.

105 GERD can incite or exacerbate allergies, sinusitis, bronchitis, and asthma.

106 ation for acute bacterial infections causing sinusitis, bronchitis, and community-acquired pneumonia.

107 mple was restricted to outpatient visits for sinusitis, bronchitis, and uncomplicated urinary tract i

108 ups: (1) those with radiographic evidence of sinusitis by CT (Sx + CT) (75) and (2) those with normal

109 ished from chronic hyperplastic eosinophilic sinusitis by the prominent expression of IFN-gamma.

110 We report a case of sinusitis caused by H. capsulatum in a patient with AIDS

111 We describe a case of invasive fungal sinusitis caused by Scytalidium dimidiatum in a lung tra

112 toms in adults with severe symptoms of acute sinusitis compared with antibiotics alone.

113 ved clinical outcomes in patients with acute sinusitis compared with placebo or nonsteroidal anti-inf

114 ed more frequently in URI visits that led to sinusitis, compared to in uncomplicated URIs (10.8% vs 3

115 cute sinusitis, or inpatient encounter for a sinusitis complication, was assessed 1 to 14 days after

116 of mucosal infections such as otitis media, sinusitis, conjunctivitis, and exacerbations of chronic

117 We review articles on rhinitis, sinusitis, conjunctivitis, and immunotherapy.

118 number of diseases, including otitis media, sinusitis, conjunctivitis, exacerbations of chronic obst

119 of Olfactory Disorders (14 points), (3) the Sinusitis Control Test (14 points), and (4) the EQ-5D (1

120 uestionnaire of Olfactory Disorders, and the Sinusitis Control Test provided the highest quality CRS-

121 ns from patients with active GPA (n = 10) or sinusitis (controls, n = 6) were s.c. co-implanted with

122 ence of asthma, eczema, chronic or recurrent sinusitis, cough, and both tension and migraine headache

123 icillin plus clavulanate for acute bacterial sinusitis diagnosed in accordance with the Infectious Di

124 Sinusitis diagnoses were more than twice as common in vi

125 is appears to be related to the high rate of sinusitis diagnosis in virtual urgent care.

126 dults treated for clinically diagnosed acute sinusitis did not appear to benefit from taking high-dos

127 irst-line antibiotic for acute uncomplicated sinusitis did not have clinically significant difference

128 In patients with a history of asthma and sinusitis, distinguishing between ANCA-negative CSS and

129 ms of asthma, otitis media with effusion and sinusitis dramatically improved.

130 n to predispose children to otitis media and sinusitis due to bacteria such as nontypeable Haemophilu

131 No bridled patients were diagnosed with sinusitis during the study period.

132 New viruses were detected in 29% of sinusitis episodes, and their pattern was different than

133 RATIONALE: The European Position Paper on Sinusitis (EPOS) guidelines provide composite criteria t

134 ry tract diseases that include otitis media, sinusitis, exacerbations of chronic obstructive pulmonar

135 Children who developed sinusitis experienced more frequent URIs, compared to ch

136 The patient was cured from Stachybotrys sinusitis following sinus surgery and antifungal treatme

137 ontrols (DOD, 10.7%; P < .001) and for acute sinusitis from 38.9% to 18.8% in intervention practices

138 Nasal lactoferrin helps distinguish sinusitis from colds.

139 age range, 8-68 years) with allergic fungal sinusitis from multiple institutions.

140 To distinguish sinusitis from uncomplicated "colds," we examined lactof

141 aged > or =16 years) with acute nonrecurrent sinusitis (had > or =2 diagnostic criteria: purulent rhi

142 eria (HESwAS; n = 20), HES without asthma or sinusitis (HES; n = 18), and normal controls (n = 8).

143 report this organism as a cause of bacterial sinusitis, highlighting its potential niche as a commens

144 coelomycetous fungus, P. lignicola, causing sinusitis in an immunocompetent patient.

145 is is an important cause of otitis media and sinusitis in children and of lower respiratory tract inf

146 latum has not typically been associated with sinusitis in either group of patients.

147 hat were the apparent causes of two cases of sinusitis in immunocompetent hosts.

148 guished from aspirin-tolerant asthma/chronic sinusitis in large part by an exuberant infiltration of

149 gens isolated from immunocompetent patients, sinusitis in patients with AIDS may be caused by a varie

150 was higher incidence of bilateral maxillary sinusitis in patients with septal deviation (p=0.007).

151 The prevalence of chronic sinusitis in the absence of systemic immune defects indi

152 ation was effective as a treatment for acute sinusitis in the primary care setting.

153 ured but followed by invasive A. calidoustus sinusitis in the setting of refractory leukemia.

154 spiratory disease in chickens and infectious sinusitis in turkeys.

155 Acute sinusitis is a common clinical problem that usually resu

156 Chronic sinusitis is a common inflammatory condition defined by

157 Allergic fungal sinusitis is a distinct clinical entity with nonspecific

158 Acute bacterial sinusitis is a frequent complication of viral upper resp

159 Acute bacterial sinusitis is common, but currently recommended antibioti

160 Sinusitis is commonly reported in patients with AIDS.

161 Sinusitis is diagnosed clinically; radiographic evaluati

162 opriate use of medical therapies for chronic sinusitis is necessary to optimize patient quality of li

163 Acute sinusitis is one of the most common indications for anti

164 with a several-fold increase in the risk of sinusitis, laryngitis, asthma, pneumonia, and bronchiect

165 dysfunction and is commonly characterized by sinusitis, male infertility, hydrocephalus, and situs in

166 g that nonneurogenic factors predominated in sinusitis mucous hypersecretion.

167 ar-olds for bronchitis (n = 76,243), chronic sinusitis (n = 15,745), otitis media (n = 237,833), pneu

168 TS) were investigated in subjects with acute sinusitis (n = 25), subjects with chronic fatigue syndro

169 rthritis (n = 1), otitis media (n = 10), and sinusitis (n = 3).

170 Chronic rhinitis/sinusitis (n = 78; 100%), recurrent otitis media (n = 74

171 re obtained on the day of diagnosis of acute sinusitis, nearly 30% of children had a new virus identi

172 Is (acute otitis media [AOM; children only], sinusitis, nonbacteremic pneumonia) and IPD attributable

173 Asthma and sinusitis occur first in the course of EGPA, followed by

174 condary complications such as bronchitis and sinusitis occurred in 15% of placebo recipients compared

175 nd esophageal stricture were associated with sinusitis (odds ratio, 1.60; 95% confidence interval, 1.

176 in patients with postnasal drainage without sinusitis or allergies.

177 subtype influenza A viruses developed either sinusitis or otitis media, while only 1 out of 11 ferret

178 olds and controls but in 79% of persons with sinusitis or purulent sputa.

179 20.30 [95% CI, 3.85-108.15]; P = .0001) and sinusitis (OR, 76.72 [95% CI, 6.48-908.15]; P = .001) we

180 , impetigo and cellulitis, otitis media, and sinusitis) or reconsultation with new or non-resolving s

181 (suppurative otitis media [OM], pharyngitis, sinusitis) or viral infection (influenza, viral upper re

182 tient diagnosis of a bacterial (pharyngitis, sinusitis) or viral respiratory infection (influenza, vi

183 department or inpatient encounter for acute sinusitis, or inpatient encounter for a sinusitis compli

184 ere were no episodes of bleeding, infection, sinusitis, or nasal septal trauma caused by the umbilica

185 to cause inflammatory diseases that include sinusitis, otitis media and exacerbations of chronic obs

186 d and in first-line antibiotic selection for sinusitis, otitis media, and pharyngitis.

187 T cells/muL and with a history of recurrent sinusitis/otitis media, frequent episodes of shingles, a

188 An immunocompetent 59-year-old man developed sinusitis over a 6- to 8-month period after cutting down

189 fluence the incidence of bilateral maxillary sinusitis (p=0.495).

190 rs with an ARTI diagnosis (acute bronchitis, sinusitis, pharyngitis, otitis media, allergic rhinitis,

191 Single cases of grade 3 treatment-related sinusitis, pneumonia, viral bronchitis, tooth infection,

192 encounters (acute otitis media, pharyngitis, sinusitis, presumed viral infection) after adjusting for

193 haryngeal decontamination, patient position, sinusitis prophylaxis, subglottic secretion drainage, tr

194 benralizumab vs. placebo included headache, sinusitis, pyrexia, and influenza.

195 benralizumab vs. placebo included headache, sinusitis, pyrexia, and influenza.

196 for 29 102 adults with a diagnosis of acute sinusitis receiving initial antibiotic treatment between

197 Sinusitis-related quality of life might improve with INC

198 on of children<9 years requiring surgery for sinusitis-related SPA has remained a minority (15%-32.5%

199 Patients</=18 years of age with sinusitis-related SPA treated from 2002 to 2012; compara

200 ine changes over time in the bacteriology of sinusitis-related subperiosteal abscess (SPA) of the orb

201 Prescribing rates for sinusitis remained stable.

202 mboembolic disease; and f) cholestasis or g) sinusitis requiring surgical intervention.

203 peritonsillar or pharyngeal abscess, otitis, sinusitis, sepsis or septic complications, recurrence of

204 d the respiratory tract [99; pneumonia (93), sinusitis (six)], bone, joint and soft tissues [26; disc

205 omplicated URI subjects and 3 (range 1-9) in sinusitis subjects (P < .001).

206 and mucin concentrations were correlated in sinusitis, suggesting that nonneurogenic factors predomi

207 es suggest little benefit in relief of acute sinusitis symptoms from the use of newer and more expens

208 We conducted network meta-analysis of sinusitis symptoms, heath-related quality of life, rescu

209 ses and orbit, vascular malformations, acute sinusitis, systemic abnormalities, barotrauma and valsal

210 tmortem examination revealed invasive fungal sinusitis that involved the sphenoid sinus and that exte

211 demonstrate their predominance in maxillary sinusitis that is associated with them.

212 the first case of invasive S. chlorohalonata sinusitis that was surgically and medically cured but fo

213 ating patients with recurrent and refractory sinusitis, the procedure is not without risk of serious

214 Complications of sinusitis, though rare, can be serious and require early

215 potential cause of asthma, atopy and chronic sinusitis through airway infection.

216 iographs for patients diagnosed with chronic sinusitis to demonstrate the method developed herein.

217 .6% of all ARI syndromes, ranging from 2.8% (sinusitis) to 11% (clinical influenza).

218 The proportion of sinusitis visits that meet antibiotic prescribing criter

219 Of 425 randomly selected sinusitis visits, 50% (214) met antibiotic prescribing c

220 Sinusitis was associated with HHV-6 isolation in autolog

221 , on Day 3-4 of the URI, and on Day 10, when sinusitis was diagnosed.

222 Allergic fungal sinusitis was more common in male patients and in patien

223 Sinusitis was present, and restrictive disorder was pred

224 Sinusitis was the single diagnosis associated with the m

225 June 201X-2, an 81-year-old man with chronic sinusitis was treated with Shini-seihai-to.

226 and smoke exposure, bacterial infection, and sinusitis, we hypothesized that components in CS might a

227 suggesting that some children deemed to have sinusitis were experiencing sequential viral infections.

228 upper jaw and their corresponding maxillary sinusitis were studied for aerobic and anaerobic bacteri

229 le developed complications; otitis media and sinusitis were the most common complications (101 patien

230 degeneration of back/neck) to 1.69 (chronic sinusitis) when compared with 1.72 to 1.80 for AKs.

231 red in immunosuppressed patients who develop sinusitis while receiving VRC prophylaxis, especially th

232 h a history of chronic rhinitis or recurrent sinusitis who present for treatment of acute rhinosinusi

233 62-year-old man with a history of recurrent sinusitis who presents with persistent upper respiratory

234 In children with acute sinusitis who were treated as outpatients, there was no

235 patients with invasive fungal rhino-orbital sinusitis who were treated with a modified treatment lad

236 central nervous system infections (n=3), and sinusitis with esophagitis (n=1).

237 sal mucosa revealed marked acute and chronic sinusitis with inflammation, congestion, and hemorrhage.

238 nt of asthma, atopic dermatitis, and chronic sinusitis with nasal polyposis.

239 hout nasal polyps, and patients with chronic sinusitis with nasal polyps (CRSwNP).

240 mpanied by chronic hyperplastic eosinophilic sinusitis with nasal polyps, blood eosinophilia, and inc

241 colonization (including ABPA); (iii) severe sinusitis with or without aspirin-exacerbated respirator

242 l sinus and chest computed tomography showed sinusitis with osteochondral destruction, bronchiectasis

243 some type 2 immune responses such as chronic sinusitis with polyps and atopic dermatitis.

244 ruses identified at the time of diagnosis of sinusitis with those identified early in the URI.

245 robable CSS; n = 21), HES with asthma and/or sinusitis without other CSS-defining criteria (HESwAS; n